These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 20610347)

  • 1. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers.
    Jansen M; Yip S; Louis DN
    Lancet Neurol; 2010 Jul; 9(7):717-26. PubMed ID: 20610347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers of glioma: an update on recent progress and perspectives.
    Gupta K; Salunke P
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):1971-81. PubMed ID: 23052697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnostics of gliomas: the clinical perspective.
    Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M
    Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnostics of gliomas: state of the art.
    Riemenschneider MJ; Jeuken JW; Wesseling P; Reifenberger G
    Acta Neuropathol; 2010 Nov; 120(5):567-84. PubMed ID: 20714900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress on molecular biomarkers and classification of malignant gliomas.
    Zhang C; Bao Z; Zhang W; Jiang T
    Front Med; 2013 Jun; 7(2):150-6. PubMed ID: 23681890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates in Pediatric Glioma Pathology.
    Hakar MH; Wood MD
    Surg Pathol Clin; 2020 Dec; 13(4):801-816. PubMed ID: 33183734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of gliomas: from morphology to molecules.
    Ferris SP; Hofmann JW; Solomon DA; Perry A
    Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population.
    Trabelsi S; Chabchoub I; Ksira I; Karmeni N; Mama N; Kanoun S; Burford A; Jury A; Mackay A; Popov S; Bouaouina N; Ben Ahmed S; Mokni M; Tlili K; Krifa H; Yacoubi MT; Jones C; Saad A; H'mida Ben Brahim D
    Mol Neurobiol; 2017 May; 54(4):2381-2394. PubMed ID: 26957305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].
    Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H
    Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers define distinct types of diffuse glioma.
    Cancer Discov; 2015 Aug; 5(8):787. PubMed ID: 26134050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular diagnostic testing in gliomas].
    Hasselblatt M
    Pathologe; 2008 Nov; 29(6):422-7. PubMed ID: 18779965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular biology of WHO grade II gliomas.
    Marko NF; Weil RJ
    Neurosurg Focus; 2013 Feb; 34(2):E1. PubMed ID: 23373446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Molecular Diagnostics on the Treatment of Glioma.
    Bush NA; Butowski N
    Curr Oncol Rep; 2017 Apr; 19(4):26. PubMed ID: 28303493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting Molecular Features of Gliomas: Genetic Loci and Validated Biomarkers.
    Arcella A; Limanaqi F; Ferese R; Biagioni F; Oliva MA; Storto M; Fanelli M; Gambardella S; Fornai F
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
    Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
    Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How molecular biology can improve the clinical diagnosis of gliomas?].
    D'Haene N; Blanchard O; De Nève N; Evens J; Maris C; Rorive S; Le Mercier M; Salmon I
    Rev Med Brux; 2016; 37(3):152-158. PubMed ID: 28525188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the application of molecular biomarkers in gliomas.
    Wang J; Su HK; Zhao HF; Chen ZP; To SS
    Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma diagnosis: immunohistochemistry and beyond.
    Dunbar E; Yachnis AT
    Adv Anat Pathol; 2010 May; 17(3):187-201. PubMed ID: 20418673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.